A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome.
Hepatology. 2022 Jun;75(6):1523-1538. doi: 10.1002/hep.32235. Epub 2021 Dec 18.
Hepatology. 2022.
PMID: 34773257